Abstract:Tumor microenvironment-activatable photosensitizers have gained significant attention for cancer theranostics. Considering the hypoxic environment of solid tumors, activatable phototheranostic agents with type I PDT are desired to obtain improved cancer treatment efficiency. Herein, we report a simple, effective and multifunctional Bodipy photosensitizer for tumor imaging and type I/II photodynamic therapy. The photosensitizer featuring a methylphenylboronic acid pinacol ester group at the meso -position of Bodipy specifically responds to tumor-abundant H 2 O 2 . Its photophysical properties were characterized using steady-state and time-resolved transient optical spectroscopies. The fluorescence ( Φ F = 0.09%) and singlet oxygen efficacy ( Φ Δ = 10.2%) of the Bodipy units were suppressed in the caged dyads but significantly enhanced ( Φ F = 0.72%, Φ Δ = 20.3%) upon H 2 O 2 activation. Fluorescence emission spectroscopy and continuous wave electron paramagnetic resonance (EPR) spectroscopy confirmed that the Bodipy photosensitizer generates reactive oxygen species (ROS) via both electron transfer-mediated type I and energy transfer-mediated type II mechanisms. In vitro experiments demonstrated rapid internalization into tumor cells, enhanced brightness stimulated by tumor microenvironments, and tumor cell death (phototoxicity, IC 50 = 0.5 μM). In vivo fluorescence imaging indicated preferential accumulation of this Bodipy photosensitizer in tumor sites, followed by decaging by tumor-abundant H 2 O 2 , further elevating the signal-to-background ratio (SBR) of imaging. Besides outstanding performance in tumor imaging, a prominent inhibition of tumor growth was observed. Given its simple molecular skeleton, this Bodipy photosensitizer is a competitive candidate for cancer theranostics.

PEGylated BODIPY Photosensitizer for Type I Dominant Photodynamic Therapy and Afterglow Imaging

A BODIPY-modified polymeric micelle for sustaining enhanced photodynamic therapy

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

Self‐Assembly Induced Photosensitization of Long‐Tailed Heavy‐Atom‐Free BODIPY Derivatives for Photodynamic Therapy

Novel BODIPY-based Nano-Biomaterials with Enhanced D-A-D Structure for NIR-triggered Photodynamic and Photothermal Therapy

Potent BODIPY-based photosensitisers for selective mitochondrial dysfunction and effective photodynamic therapy

BODIPY-doped Silica Nanoparticles with Reduced Dye Leakage and Enhanced Singlet Oxygen Generation.

Metabolizable Photosensitizer with Aggregation-Induced Emission for Photodynamic Therapy

An AIE-active type I photosensitizer based on N,N′-diphenyl-dihydrophenazine for high-performance photodynamic therapy under hypoxia

A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy

A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT

Auto-Deactivation of BODIPY-Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia.

Acceptor Substitution Engineering of BODIPY-based Organic Photosensitizers with Aggregation-Induced Emission for Organelle Localization and Photodynamic Anticancer Therapy

De Novo Design of Type-l Photosensitizers Agents Based on Structure-Inherent Low Triplet Energy for Hypoxia Photodynamic Therapy

Single molecular-based nanoparticles with aggregation-induced emission characteristics for fluorescence imaging and efficient cancer phototherapy

Efficient type I and type II ROS generated aggregation-induced emission photosensitizer for mitochondria targeted photodynamic therapy

Optimizing Photosensitizers with Type I and Type II ROS Generation Through Modulating Triplet Lifetime and Intersystem Crossing Efficiency

pH-Sensitive and Lysosome Targetable Photosensitizers Based on BODIPYs

Rational design of type-I photosensitizer molecules for mitochondrion-targeted photodynamic therapy

Discovery of a Monoiodo Aza-BODIPY Near-Infrared Photosensitizer: in Vitro and in Vivo Evaluation for Photodynamic Therapy

Mitochondria-targeting BODIPY-loaded Micelles As Novel Class of Photosensitizer for Photodynamic Therapy